ÐÓ°ÉÔ­´´

CarThera, based in Paris, aims to revolutionize treatments for brain disorders with its ultrasound-based medical devices. The company focuses on non-invasive procedures, addressing the high risks and lengthy recovery times associated with traditional surgeries and medications. CarThera's technology offers potentially more effective solutions with fewer side effects, improving patient outcomes. Supported by investors like Unorthodox Ventures, CarThera appears poised for technological advancement and market penetration. As the demand for safer and more efficient treatments grows, CarThera has a unique opportunity to become a leader in the health tech industry.